You are here

  • Home
  • Archive
  • Volume 72, Issue Suppl 3
  • SAT0488 Sensitivity to Change of a Combined Gray-Scale and Power Doppler Ultrasound Score for Synovitis in Comparison to a Sum Score of 5 Joints of the Wrist and Hand – One-Year Evaluation of an RA Cohort.

Article Text

Article menu
Download PDFPDF
Scientific Abstracts
Diagnostics and imaging procedures
SAT0488 Sensitivity to Change of a Combined Gray-Scale and Power Doppler Ultrasound Score for Synovitis in Comparison to a Sum Score of 5 Joints of the Wrist and Hand – One-Year Evaluation of an RA Cohort.
  1. S. Ohrndorf1,
  2. M.-A. D’Agostino2,
  3. B. Schicke3,
  4. R. J. Wakefield4,
  5. L. Vogler1,
  6. J. Messerschmidt1,
  7. B. E. Reiche1,
  8. G.-R. Burmester1,
  9. E. Naredo5,
  10. A. Iagnocco6,
  11. M. Backhaus1
  1. 1Department of Rheumatology and Clinical Immunology, CHARITE UNIVERSITY HOSPITAL, Berlin, Germany
  2. 2Université Paris Île de France Ouest-Versailles-Saint Quentin en Yvelines, Paris, France
  3. 3Tumorzentrum Berlin, CHARITE UNIVERSITY HOSPITAL, Berlin, Germany
  4. 4Section of Musculoskeletal Disease, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds, United Kingdom
  5. 5Hospital General Universitario Gregorio Marañón, Madrid, Spain
  6. 6Dipartimento di Medicina Interna e Specialità Mediche Reumatologia, Sapienza Università di Roma, Rome, Italy

Abstract

Background Several ultrasound (US) scoring systems have been proposed for evaluating objectively RA patients’ responsiveness under treatment [1-3].

Objectives To evaluate the sensitivity to change over one year of a combined gray-scale (GS) and power Doppler (PD) US score in RA patients taking different anti-rheumatic therapies in comparison to synovitis sum scores of 5 joints (US5).

Methods USdata of 77 RA patients have been surveyed over the time of one year since inclusion of each patient. The clinically most affected hand (wrist and finger joints) was semi-quantitatively (0-3) assessed by GS and PDUS for synovitis (synovial fluid and/or synovial hypertrophy) [4]. In detail, radiocarpal, ulnocarpal and midcarpal wrist as well as the MCP2-5 and PIP2-5 joints were examined from dorsal and palmar at baseline, and 3, 6, 12 months after initiation/change of therapy (DMARD/Biologic). The combined score was the highest of either the GS or PDUS score with the same weight at joint level [5]. Each combined score was correlated to the 5-joint sum score of the wrist and hand (dorsal ulnocarpal, dorsal and palmar midcarpal regions, dorsal (only PDUS) and palmar MCP2,3 and PIP2,3 regions according to [2] without forefoot) at patient level each in GS and PDUS. Clinical examination by DAS28 was performed at the same time points than US. Correlations between the combined scores, the GS/PDUS5, and DAS28 were obtained by Spearman’s correlation coefficient.

Results After baseline examination, 71.2% of included patients were on Biologic and 28.8% on DMARD therapy. The combined scores demonstrated longitudinal significant correlations with the DAS28 only in the dorsal midcarpal (r=0.29, p=0.015) and ulnocarpal (r=0.24, p=0.47) wrist regions, whereas the US5 sum score presented higher significant correlations both in GS (r=0.42, p<0.01) and PDUS (r=0.54, p<0.01). Including all time points, the highest correlations between the joint-level combined scores and the GSUS5 score were found for the following joint regions: midcarpal wrist from palmar (r=0.69) and from dorsal (r=0.63), ulnocarpal wrist (r=0.73), palmar MCP2 (r=0.76), palmar MCP3 (r=0.66; each p<0.01).

Conclusions Considering the whole patient group independently from therapy, the proposed combined score was only sensitive to change at the wrist joint level (dorsal midline and ulnocarpal) under different anti-rheumatic therapies. The US5 sum score was higher responsive independently from the US modality (GS/PDUS).

References

  1. Naredo E, et al. Clin Exp Rheumatol 2005;23(6):881-4.

  2. Backhaus M, et al. Arthritis Rheum 2009;61(9):1194-1201.

  3. Perricone C, et al. Rheumatology (Oxford) 2012;51:866-73.

  4. Wakefield RJ, et al. J Rheumatol 2005;32:2485–7.

  5. Naredo E, et al. J Rheumatol. 2011 Sep;38(9):2063-7.

References

Disclosure of Interest None Declared

https://doi.org/10.1136/annrheumdis-2013-eular.2212

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.